OnCoCross Co Ltd
KOSDAQ:382150
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
O
|
OnCoCross Co Ltd
KOSDAQ:382150
|
KR |
|
Corbion NV
AEX:CRBN
|
NL |
|
L
|
Labrador Iron Ore Royalty Corp
OTC:LIFZF
|
CA |
|
Anritsu Corp
F:AN1
|
JP |
|
V
|
Velocity Minerals Ltd
F:VMSP
|
CA |
|
Universal Ibogaine Inc
XTSX:IBO
|
CA |
|
O
|
Obzen Inc
KOSDAQ:417860
|
KR |
|
G
|
Global Energy Metals Corp
OTC:GBLEF
|
CA |
|
N
|
Nam Viet Corp
VN:ANV
|
VN |
|
Arfin India Ltd
BSE:539151
|
IN |
|
Ascopiave SpA
F:AVA
|
IT |
|
TGS ASA
F:TGC0
|
NO |
|
C
|
Century Insurance Company Ltd
KAR:CENI
|
PK |
|
America's CAR-MART Inc
NASDAQ:CRMT
|
US |
|
N
|
Nanjing Panda Electronics Co Ltd
SSE:600775
|
CN |
|
Kobe Steel Ltd
OTC:KBSTF
|
JP |
|
Madoro Metals Corp
OTC:MSTXF
|
CA |
|
Thomson Medical Group Ltd
F:3H5
|
SG |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de OnCoCross Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace OnCoCross
Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-12-18. The firm mainly develops artificial intelligence (AI) new drug development platform based on its original technology which analyzing changes in gene expression data (Transcriptome) due to drug administration or disease occurrence and using AI to match the optimal disease and treatment.
- Sede central
- Corea KR
- Empleados
- 31
- Fecha de salida a bolsa
- 18 dic., 2024
